Table 3.
Comparison of the serum parameters for oxidative stress and antioxidants.
| Measurements | Healthy subjects (Total 82, M 27/F 55) |
ICF subjects (Total 103, M 20/F 83) |
|---|---|---|
| TAC (μM) Male/Female |
312.8 ± 55.6 325.5 ± 56.8/307.2 ± 54.8 |
232.8 ± 46.6** 231.7 ± 44.7**/233.0 ± 47.4** |
| Catalase (unit/mL) Male/Female |
337.4 ± 193.8 401.2 ± 203.0/300.5 ± 180.4 |
197.0 ± 72.6** 246.6 ± 45.2**/183.9 ± 73.0** |
| SOD (unit/mL) Male/Female |
2.4 ± 0.9 2.4 ± 0.9/2.4 ± 1.0 |
1.6 ± 0.7** 1.5 ± 0.8**/1.6 ± 0.7** |
| Total GSH contents (μM) Male/Female |
54.6 ± 48.5 68.4 ± 59.3/46.2 ± 39.0 |
28.8 ± 37.1** 42.5 ± 24.6/24.9 ± 39.1** |
| GSH/GSSG ratio Male/Female |
14.6 ± 4.2 17.8 ± 3.1/11.8 ± 2.8 |
11.1 ± 2.5** 13.4 ± 1.5**/9.6 ± 2.8* |
| GSH-peroxidase (unit/mL) Male/Female |
0.81 ± 0.86 0.81 ± 0.58/0.81 ± 0.95 |
0.36 ± 0.14* 0.37 ± 0.16*/0.36 ± 0.14 |
| GSH-reductase (unit/mL) Male/Female |
0.52 ± 0.12 0.62 ± 0.12/0.47 ± 0.10 |
0.23 ± 0.10** 0.13 ± 0.07**/0.26 ± 0.09** |
| HO-1 (ng/mL) Male/Female |
1.8 ± 0.8 1.9 ± 1.0/1.7 ± 0.7 |
2.0 ± 0.9 2.7 ± 1.1*/1.8 ± 0.6 |
| TNF-alpha (pg/mL) Male/Female |
23.9 ± 16.4 21.4 ± 10.4/25.0 ± 18.3 |
57.2 ± 42.5** 54.2 ± 45.8**/58.0 ± 41.9** |
| IFN-gamma (pg/mL) Male/Female |
30.3 ± 28.0 30.6 ± 28.0/30.2 ± 28.4 |
25.3 ± 39.3 33.6 ± 69.2/22.9 ± 25.9 |
Data are expressed as the average ± SD. **The statistical significance between healthy and ICF was observed as *p < 0.05 or **p < 0.01.